ESMO 25: Padcev/Keytruda Reduces Risk Of Death By Half In Bladder Cancer Trial

 
• By Kevin Grogan
  
Berlin is hosting this year's ESMO (Kevin Grogan)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas